Novo Nordisk Aktie

59,76EUR 0,19EUR 0,32%
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 91,04
Novo Nordisk Fonden 7,29
Government Pension Fund - Global (The) 2,29
Alecta Pension 1,54
Vanguard Total International Stock Index Fund 1,42
Fundsmith Equity Fund 0,95
Vanguard Developed Markets Index Fund 0,57

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 40 638 41 971 42 076 43 202 43 258
Umsatz pro Mitarbeiter in Mio. EUR 2,66 2,66 2,65 2,59 2,82

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 55 140 59 766 60 080 59 067 62 456
Summe Anlagevermögen 48 042 45 498 51 509 52 354 62 076
Summe Aktiva 91 799 97 539 102 355 110 769 125 612

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 1 073 229 1 694 515 4 483
Summe Fremdkapital 44 830 52 270 52 540 58 930 68 019
Summe Eigenkapital 46 969 45 269 49 815 51 839 57 593
Summe Passiva 91 799 97 539 102 355 110 769 125 612

Adresse

Novo Allé, 2880 Bagsværd
Internet http://www.novonordisk.com

Management

Andreas Fibig
Independent Director
Anne Marie Handrup Kverneland
Director
Brian F. Daniels
Independent Director
Camilla Sylvest
EVP-Commercial Strategy & Corporate Affairs
Doug Langa
EVP & Head-North America Operations
Elizabeth Anne Hewitt
Independent Director
Helge Lund
Chairman
Henrik Ehlers Wulff
Executive Vice President-Product Supply & Quality
Jeppe Fonager Christiansen
Vice Chairman
Karsten Munk Knudsen
Chief Financial Officer & Executive Vice President
Kasim Kutay
Director
Lars Fruergaard Jørgensen
President & Chief Executive Officer
Laurence Debroux
Independent Director
Ludovic Helfgott
Executive Vice President & Head-Biopharm
Mads Krogsgaard Thomsen
Chief Science Officer & Executive Vice President
Martin Holst Lange
Senior Vice President-Global Development
Martin W. MacKay
Independent Director
Maziar Mike Doustdar
Executive Vice President-International Operations
Mette Bøjer Jensen
Director
Monique Carter
Executive Vice President-People & Organisation
Peter Hugreffe Ankersen
Vice President & Head-Investor Relations
Peter Jens Lindholm Kurtzhals
Senior Vice President-Global Research
Robin Evers
SVP-Medical Affairs, Regulatory & Safety
Sergey Manelis
Commercial Director
Stephen Gough
Global Chief Medical Officer
Stig Strøbæk
Director
Sylvie Louise Grégoire
Independent Director
Thomas Rantzau
Director